CHAPTER 4: Current Status and Future Direction of Fragment-Based Drug Discovery: A Computational Chemistry Perspective
-
Published:17 Jun 2015
-
Special Collection: 2015 ebook collection , 2011-2015 industrial and pharmaceutical chemistry subject collectionSeries: Drug Discovery Series
I. D. Wall, M. M. Hann, A. R. Leach, and S. D. Pickett, in Fragment-Based Drug Discovery, ed. S. Howard and C. Abell, The Royal Society of Chemistry, 2015, pp. 73-100.
Download citation file:
Fragment-based drug discovery (FBDD) has become a well-established and widely used approach for lead identification. The computational chemistry community has played a central role in developing the ideas behind this area of research and computational tools are important throughout FBDD campaigns. This article discusses the evolution of best practice, on-going areas of debate and gaps in current capabilities from a computational chemistry perspective. In particular, the contribution of computational methods to areas such as fragment library design, screening analysis, data handling and the role of structure- and ligand-based design is discussed. The potential to combine FBDD with other hit-identification methods such as high-throughput screening in a more integrated approach is also highlighted.